Stimulant Overdose

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Stimulant Overdose trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 2/3

NCT06633900

Naltrexone for Overdose Prevention

The goal of this clinical trial is to see if an injectable medicine called naltrexone can prevent fentanyl overdose deaths in people who use other drugs (cocain…

United States100 participantsStarted 2025-04-10

Treatment: IM naltrexone, Usual Care

All recent trials (8 shown)

CompletedNot Applicable

NCT06609278

THRIVE: Culturally AdapTed Harm Reduction Intervention

The goal of this study is to develop and test a culturally adapted harm reduction intervention among Black adults who misuse opioids and/or stimulants. The ques…

United States57 participantsStarted 2025-04-02

Treatment: harm reduction intervention

Not Yet RecruitingNot Applicable

NCT07179614

Kentucky Women's Justice Community Overdose Innovation Network - Phase II

This project continues our work with women in the Kentucky Women's Justice Community Overdose Innovation Network Phase II (WJCOIN-II) with the overall aim of re…

United States300 participantsStarted 2026-05-18

Treatment: Overdose Prevention Intervention Package (OPIP)

Stimulant Overdose

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Naltrexone for Overdose Prevention

All recent trials (8 shown)

THRIVE: Culturally AdapTed Harm Reduction Intervention

Kentucky Women's Justice Community Overdose Innovation Network - Phase II

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Naltrexone for Overdose Prevention

All recent trials (8 shown)

THRIVE: Culturally AdapTed Harm Reduction Intervention

Kentucky Women's Justice Community Overdose Innovation Network - Phase II

Remote Fentanyl Test Strip Distribution and Education to Prevent Drug Overdose

Evaluation of a Novel Intervention to Prevent Polysubstance Overdoses Involving Illicit Stimulants

Beginning Early and Assertive Treatment for Methamphetamine Use Disorder

Stimulant Overdose in the Medicaid Population: Who is at Risk, and When Are They at Risk

Leveraging Psychological Autopsies to Accelerate Research Into Stimulant Overdose Mortality